These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 37957424)

  • 1. Does COVID-19 Trigger the Risk for the Development of Parkinson's Disease? Therapeutic Potential of Vitamin C.
    Sandeep ; Subba R; Mondal AC
    Mol Neurobiol; 2023 Nov; ():. PubMed ID: 37957424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.
    Conte C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-COV-2 infection and Parkinson's disease: Possible links and perspectives.
    Al-Kuraishy HM; Al-Gareeb AI; Kaushik A; Kujawska M; Ahmed EA; Batiha GE
    J Neurosci Res; 2023 Jun; 101(6):952-975. PubMed ID: 36717481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of SARS-CoV-2 on the development of Parkinson's disease: the role of α-synuclein.
    Iravanpour F; Farrokhi MR; Jafarinia M; Oliaee RT
    Hum Cell; 2024 Jan; 37(1):1-8. PubMed ID: 37735344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-COVID-19 Parkinsonism and Parkinson's Disease Pathogenesis: The Exosomal Cargo Hypothesis.
    Mysiris DS; Vavougios GD; Karamichali E; Papoutsopoulou S; Stavrou VT; Papayianni E; Boutlas S; Mavridis T; Foka P; Zarogiannis SG; Gourgoulianis K; Xiromerisiou G
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
    Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
    Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could Vitamins Have a Positive Impact on the Treatment of Parkinson's Disease?
    Sandeep ; Sahu MR; Rani L; Kharat AS; Mondal AC
    Brain Sci; 2023 Feb; 13(2):. PubMed ID: 36831815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Infection Enhances Susceptibility to Oxidative Stress-Induced Parkinsonism.
    Smeyne RJ; Eells JB; Chatterjee D; Byrne M; Akula SM; Sriramula S; O'Rourke DP; Schmidt P
    Mov Disord; 2022 Jul; 37(7):1394-1404. PubMed ID: 35579496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson's Disease.
    Angelopoulou E; Karlafti E; Georgakopoulou VE; Papalexis P; Papageorgiou SG; Tegos T; Savopoulos C
    Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy.
    Sinha S; Mittal S; Roy R
    J Mov Disord; 2021 Sep; 14(3):184-192. PubMed ID: 34315206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice.
    Parrella E; Bellucci A; Porrini V; Benarese M; Lanzillotta A; Faustini G; Longhena F; Abate G; Uberti D; Pizzi M
    Transl Neurodegener; 2019; 8():16. PubMed ID: 31139367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson's Disease: A Narrative Review.
    Morowitz JM; Pogson KB; Roque DA; Church FC
    Brain Sci; 2022 Apr; 12(5):. PubMed ID: 35624923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione
    Jewett M; Dickson E; Brolin K; Negrini M; Jimenez-Ferrer I; Swanberg M
    Front Neurol; 2018; 9():222. PubMed ID: 29681884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncovering Novel Therapeutic Targets for Parkinson's Disease.
    Soni R; Delvadia P; Joharapurkar A; Shah J
    ACS Chem Neurosci; 2023 Jun; 14(11):1935-1949. PubMed ID: 37227448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment.
    Atiq A; Lee HJ; Khan A; Kang MH; Rehman IU; Ahmad R; Tahir M; Ali J; Choe K; Park JS; Kim MO
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease.
    Riederer P; Monoranu C; Strobel S; Iordache T; Sian-Hülsmann J
    J Neural Transm (Vienna); 2021 Oct; 128(10):1577-1598. PubMed ID: 34636961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding multifactorial architecture of Parkinson's disease: pathophysiology to management.
    Kaur R; Mehan S; Singh S
    Neurol Sci; 2019 Jan; 40(1):13-23. PubMed ID: 30267336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease.
    Deng I; Corrigan F; Zhai G; Zhou XF; Bobrovskaya L
    Brain Behav Immun Health; 2020 Apr; 4():100060. PubMed ID: 34589845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.